(Q86524071)
Statements
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation (English)
Amanda R Harrington
Edward P Armstrong
Paul E Nolan
Daniel C Malone
scientific article published on 02 April 2013
No description defined